AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

How Big Pharma Companies Can Win in Emerging Markets | Infiniti’s Latest Blog Reveals Key Success Strategies

December 31, 2019 GMT
How Big Pharma Companies Can Win in Emerging Markets | Infiniti’s Latest Blog Reveals Key Success Strategies
How Big Pharma Companies Can Win in Emerging Markets | Infiniti’s Latest Blog Reveals Key Success Strategies

LONDON--(BUSINESS WIRE)--Dec 31, 2019--

A well-known market intelligence company, Infiniti Research, has announced the completion of its latest article on how big pharma can compete effectively in emerging markets. This blog provides comprehensive insights on:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191231005106/en/

How big pharma companies can succeed in emerging markets. (Graphic: Business Wire)

Emerging markets are highly promising and offer a plethora of opportunities for pharmaceutical companies. As a result, there is an unprecedented growth in pharma companies turning to emerging markets such as Brazil, India, and China to set up their businesses. Pharma industry experts at Infiniti Research believe that big pharma companies that are innovative and advanced in terms of manufacturing, logistics and distribution, and understanding customer needs are more likely to gain an edge over the others in these coveted markets.

Despite several efforts, some big pharma companies often fail to gain a major foothold in these regions. This issue occurs due to several reasons. Sometimes, new entrants in the big pharma market discover that operating and selling in emerging markets can be challenging due to market access requirements including manufacturing, logistics, and supply chain can be complex. Furthermore, unfavorable regulatory environment, dynamic pricing and reimbursement practices, and talent management challenges also pose major challenges for big pharma companies in emerging markets.

One of the primary steps in establishing and executing a growth strategy for big pharma companies involves identifying commonalities across markets. These commonalities must support cost-effective approaches while considering the unique regulatory constraints and consumer attributes of different regions.

Growth strategies for big pharma companies are increasingly dependent on expansion into emerging markets. Request a free proposal for more insights on how we can help support your market expansion plan into emerging markets.

You may also like to read some of our recent articles on the pharma industry:

Is your business experiencing a slump in sales? It can be revived and brought back to track with the right market intelligence solutions to guide your decision-making process. Get in touch with our industry experts for more insights on how our tailor-made solutions can cater to your specific business challenges.

About Infiniti Research

Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us

View source version on businesswire.com:https://www.businesswire.com/news/home/20191231005106/en/

CONTACT: Infiniti Research

Anirban Choudhury

Marketing Manager

US: +1 844 778 0600

UK: +44 203 893 3400

https://www.infinitiresearch.com/contact-us

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Infiniti Research

Copyright Business Wire 2019.

PUB: 12/31/2019 08:01 AM/DISC: 12/31/2019 08:01 AM

http://www.businesswire.com/news/home/20191231005106/en